CRIS Current Research Information System

PALMERINI, TULLIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.202
AS - Asia 5.888
EU - Europa 3.965
AF - Africa 408
SA - Sud America 338
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
AN - Antartide 1
Totale 16.816
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.117
VN - Vietnam 1.912
SG - Singapore 1.506
CN - Cina 1.295
GB - Regno Unito 865
IT - Italia 607
DE - Germania 572
SE - Svezia 490
HK - Hong Kong 393
FR - Francia 262
IN - India 251
BR - Brasile 235
UA - Ucraina 224
RU - Federazione Russa 193
IE - Irlanda 170
NL - Olanda 165
JP - Giappone 106
CI - Costa d'Avorio 103
KR - Corea 93
ZA - Sudafrica 88
CH - Svizzera 74
FI - Finlandia 74
SC - Seychelles 70
BG - Bulgaria 68
TG - Togo 62
EE - Estonia 60
JO - Giordania 54
NG - Nigeria 54
PH - Filippine 47
CA - Canada 46
AR - Argentina 41
IQ - Iraq 30
BE - Belgio 27
BD - Bangladesh 26
TH - Thailandia 26
IR - Iran 24
MX - Messico 24
PL - Polonia 23
AT - Austria 21
EC - Ecuador 19
TR - Turchia 18
PK - Pakistan 15
TW - Taiwan 13
CL - Cile 12
ES - Italia 12
UZ - Uzbekistan 12
CO - Colombia 11
ID - Indonesia 11
LT - Lituania 11
SA - Arabia Saudita 11
EG - Egitto 9
RO - Romania 9
AU - Australia 8
MY - Malesia 8
PY - Paraguay 7
GR - Grecia 6
HR - Croazia 6
OM - Oman 6
TN - Tunisia 6
DK - Danimarca 5
JM - Giamaica 5
KZ - Kazakistan 5
NP - Nepal 5
PE - Perù 5
LV - Lettonia 4
PT - Portogallo 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
LB - Libano 3
MA - Marocco 3
MN - Mongolia 3
AM - Armenia 2
AO - Angola 2
ET - Etiopia 2
GT - Guatemala 2
IL - Israele 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
ML - Mali 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AQ - Antartide 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
DZ - Algeria 1
FJ - Figi 1
FK - Isole Falkland (Malvinas) 1
GA - Gabon 1
GE - Georgia 1
GI - Gibilterra 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
Totale 16.803
Salva come PNG Salva come JPEG
Città #
Singapore 1.050
Southend 719
Ashburn 690
Fairfield 543
Ho Chi Minh City 437
Chandler 436
Hanoi 380
Hong Kong 366
San Jose 364
Santa Clara 305
Wilmington 249
Woodbridge 249
Seattle 242
Houston 229
Princeton 203
Beijing 186
Cambridge 183
Dong Ket 182
Ann Arbor 176
Dublin 169
Hefei 168
Jacksonville 148
Boardman 136
New York 119
Abidjan 102
Lauterbourg 96
Bologna 93
Los Angeles 93
Tokyo 88
Westminster 80
Padova 71
Da Nang 69
Berlin 68
Bern 68
Turin 67
Sofia 64
Lomé 62
Nanjing 62
Seoul 61
Buffalo 56
Milan 56
Amman 54
Bremen 54
Haiphong 54
Abeokuta 53
Munich 50
Frankfurt am Main 47
Helsinki 47
Dallas 46
The Dalles 39
Saint Petersburg 38
Jinan 37
San Diego 35
Redondo Beach 32
Guangzhou 31
Chicago 30
Nanchang 30
Mülheim 29
Changsha 28
Shanghai 28
Biên Hòa 26
Brussels 26
London 26
Rome 26
Johannesburg 24
Tianjin 23
Dearborn 22
Medford 22
Pune 21
Shenyang 21
São Paulo 21
Falkenstein 20
Phoenix 20
Turku 20
Yubileyny 20
Can Tho 19
Quận Bình Thạnh 19
Jiaxing 18
Lanzhou 18
Hebei 17
Mahé 17
Zhengzhou 17
Falls Church 16
Florence 16
Baghdad 15
Des Moines 15
Thái Nguyên 15
Verona 15
Washington 15
Ha Long 14
Hải Dương 14
Mountain View 14
Orem 14
Toronto 14
Warsaw 14
Amsterdam 13
Bengaluru 13
Bắc Ninh 13
Ninh Bình 13
Olalla 13
Totale 10.666
Salva come PNG Salva come JPEG
Nome #
Female gender and mortality in ST-segment-elevation myocardial infarction treated with primary PCI 278
A randomised study comparing the antiplatelet and antinflammatory effect of clopidogrel 150mg/day versus 75mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: Results from the DOUBLE study. 269
The role of the vascular surgeon in transcatheter aortic valve implantation 260
A Comparison Between Coronary Angioplasty and Coronary Artery Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna Registry). 260
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 254
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system. 245
Detection of Tissue Factor Antigen and Coagulation Activity in Coronary Artery Thrombi Isolated from Patients with ST-Segment Elevation Acute Myocardial Infarction 245
A randomised comparison between clopidogrel 150 mg daily maintenance dose versus 75 mg in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention 236
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 228
Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy. 221
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 220
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 210
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 207
32P brachytherapy in the treatment of complex Cypher in-stent restenosis. 203
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 203
In vitro thrombogenicity of drug-eluting and bare metal stents 201
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people 201
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system 200
Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) 197
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 194
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 191
Prognostic Significance of Baseline White Blood Cell Count in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. 190
Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients 190
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 188
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 185
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 184
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 183
Incidence, treatment and outcome of acute coronary syndromes: A community-based study in the era of myocardial infarction networks. 183
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 183
Elevati livelli pre-procedurali della proteina C-reattiva predicono la mortalita a 9 mesi dall'angioplastica del tronco comune non protetto. 181
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 179
Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods. 179
A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged > or =75 years). 177
Detection of tissue factor antigen and coagulation activity in coronary artery thrombi isolated from patients with ST-segment elevation acute myocardial infarction 177
A comparison between coronary artery bypass grafting surgery and drug eluting stent for the treatment of unprotected left main coronary artery disease in elderly patients (aged ³ 75 years) 176
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 176
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 176
Preprocedural Levels of C-Reactive Protein and Leukocyte Counts Predict 9-Month Mortality After Coronary Angioplasty for the Treatment of Unprotected Left Main Coronary Artery Stenosis. 175
Risk of stroke with coronary artery bypass graft surgery compared with percutaneous coronary intervention. 172
Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? 171
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 168
La brachiterapia endocoronarica nei pazienti diabetici con ristenosi intrastent. 168
Simultaneous versus staged approach in transcatheter aortic valve implantation for severe stenosis and endovascular aortic repair for thoracic and abdominal aortic aneurysm 166
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 166
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting 164
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 163
Defining high-risk patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention: A comparison among different scoring systems and clinical definitions 160
Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: The GEPRESS study 160
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 159
Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients. 159
Impact of Elective, Uncomplicated Target Lesion Revascularization on Cardiac Mortality After Elective Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease 159
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 158
Stent thrombosis with everolimus-eluting stents: meta-analysis of comparative randomized controlled trials. 158
Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: An individual patient data pairwise and network meta-analysis 158
Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction. 157
Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry 157
Riduzione del tempo di ritardo terapeutico e della mortalità ospedaliera nei pz con STEMI grazie ad un programma di accesso rapido alla PTCA primaria 155
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 155
Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention 154
Residual aortic regurgitation is a major determinant of late mortality after transcatheter aortic valve implantation 154
Percutaneous revascularization of left main: Role of imaging, techniques and adjunct pharmacology 152
Clinical impact of direct referral to primary percutaneous coronary intervention following pre-hospital diagnosis of ST-elevation myocardial infarction. 151
Predicting and improving outcomes of transcatheter aortic valve replacement in older adults and the elderly 149
Correlation between aortic root dimension and coronary ectasia 147
Coronary ectasia in different scenarios, primarily in myocardial infarction with nonobstructive coronary artery disease 145
SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI) 143
Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction trial 143
Risk of stroke with percutaneous coronary intervention compared with on-pump and off-pump coronary artery bypass graft surgery: Evidence from a comprehensive network meta-analysis. 142
Risk of stroke in patients with high on clopidrogel platelet reactivity to ADP after percutaneous coronary intervention: systematic review and meta-analysis 142
Recapture of the Sapien-3 Delivery System After Transversal Balloon Rupture Using a Whole Percutaneous Femoral Approach 142
Predictors of beta-brachytherapy failure in patients with high-risk in-stent restenosis 141
Description of an In-vitro of Stent Perfusion to Study Stent Thrombosis at Different Shear Rates 140
One-year outcome of patients eligible to transcatheter aortic valve implantation according to actual treatment 140
Sino-tubular junction to sinuses of Valsalva ratio: An echocardiographic parameter to predict coronary artery ectasia in patients with aortic enlargement 140
Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis. 139
Ruolo del fattore tissutale circolante nel determinare la trombosi di stent in un sistema di perfusione in vitro. 138
Influence of C-reactive protein on the effectiveness of IIb/IIIa agents in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 137
Early invasive strategy (< 24 hours) in patients with acute coronary syndromes: Weighing the evidence 134
Risk-Benefit of 1-Year DAPT After DES Implantation in Patients Stratified by Bleeding and Ischemic Risk 133
Prognostic importance of ventricular arrhythmia in patients treated with percutaneous coronary intervention. 132
Risk-benefit profile of longer-than-1-year dual-antiplatelet therapy duration after drug-eluting stent implantation in relation to clinical presentation a pairwise meta-analysis of 6 trials and 21 457 patients 131
Impact of coronary bypass or stenting on mortality and myocardial infarction in stable coronary artery disease 130
Reply: Can We State That Placing a Stent Is Sufficient? 130
Mortality Following Nonemergent, Uncomplicated Target Lesion Revascularization After Percutaneous Coronary Intervention: An Individual Patient Data Pooled Analysis of 21 Randomized Trials and 32,524 Patients 128
Importance and limits of pre-hospital electrocardiogram in patients with ST elevation myocardial infarction undergoing percutaneous coronary angioplasty 127
Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial 121
Routine minimalist transcatheter aortic valve implantation with local anesthesia only 121
Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR: The Hostile Registry 118
Biolimus-a9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 118
Development and validation of the D-PACE scoring system to predict delayed high-grade conduction disturbances after transcatheter aortic valve implantation 114
Risk of Stroke of Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease: a Systematic Review and Meta-analysis of Contemporary Randomized Clinical Trials 112
Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial. 112
Long-term outcome of prosthesis-patient mismatch after transcatheter aortic valve replacement 111
Transcatheter Aortic Valve Replacement for Pure Aortic Regurgitation in a Large and Noncalcified Annulus 110
Surgical risk scores applied to transcatheter aortic valve implantation: Friends or foes? short-term and long-term outcomes from a single-center registry 108
Reduced Mortality With Antiplatelet Therapy Deescalation After Percutaneous Coronary Intervention in Acute Coronary Syndromes: A Meta-Analysis 104
Efficacia a lungo termine della brachiterapia endocoronarica beta (32P) nel trattamento delle ristenosi intrastent ad elevato rischio. Risultati prospettici di un registro monocentrico 104
Off-Label Use of Balloon-Expandable Transcatheter Valves to Treat Pure Aortic Regurgitation 101
Predictors of bail-out stenting in patients with small vessel disease treated with drug-coated balloon percutaneous coronary intervention 101
Coronary Stent Infection and Subsequent Abscessualization Causing Dislocation in Extravascular Position 98
Totale 16.475
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.045
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021408 0 0 0 0 0 0 0 0 0 0 62 346
2021/20221.807 194 75 122 164 137 93 35 126 54 130 380 297
2022/20232.185 196 266 128 254 173 179 55 123 394 71 208 138
2023/2024622 46 84 31 78 53 206 19 28 14 34 13 16
2024/20252.497 124 375 196 189 426 162 98 68 30 207 85 537
2025/20265.949 697 598 462 454 634 318 718 281 1.188 464 135 0
Totale 17.139